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Caspase-8 is required for extrinsic apoptosis, but
is also central for preventing a pro-inflammatory
receptor interacting protein kinase (RIPK) 3–mixed
lineage kinase domain-like (MLKL)-dependent cell
death pathway termed necroptosis. Despite these
critical cellular functions, the impact of capase-8
deletion in the myeloid cell lineage, which forms
the basis for innate immune responses, has remained
unclear. In a recent article in Arthritis Research &
Therapy, Cuda et al. report that myeloid cell-restricted
caspase-8 loss leads to a very mild RIPK3-dependent
inflammatory phenotype. The presented results
suggest that inflammation does not arise exclusively
because of RIPK3-mediated necroptotic death but
that, in the absence of caspase-8, RIPK1 and RIPK3
enhance microbiome-driven Toll-like receptor-induced
pro-inflammatory cytokine production.via direct caspase-8-mediated proteolytic cleavage [5] or byThe recent article by Cuda et al. published in Arthritis
Research & Therapy [1] characterizes abnormal immune
responses in mice lacking caspase-8 in myeloid cells.
This research advances our understanding of caspase-8
function in monocytes, macrophages and neutrophils,
which has been difficult to study because of the embry-
onic lethality of whole organism caspase-8 deficiency.
Caspase-8 is a cysteine–aspartic acid protease noted
for its critical role in inducing death receptor and Toll-
like receptor (TLR)-mediated apoptosis [2]. Caspase-8 is
expressed as a monomeric zymogen, which requires
dimerization and cleavage to achieve full activity. Upon
ligand binding, death receptors such as Fas and tumour* Correspondence: vince@wehi.edu.au
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protein Fas-associated death domain (FADD) that serves
as a docking platform for pro-caspase-8 molecules and
enables caspase-8 dimerization and transactivation.
Active caspase-8 subsequently initiates apoptosis via
proteolytic activation of downstream effector caspases.
Caspase-8 activation has therefore been suggested as a
promising approach for developing new anti-cancer
therapies [3]. On the other hand, caspase-8 mutation
causes lymphoproliferative disorder and immunodefi-
ciency in people, and reduced caspase-8 expression is
associated with atopic dermatitis and epidermal wound
responses [4].
Recent mouse studies have uncovered additional roles
for caspase-8 in regulating cell death and inflammatory
responses, which may help explain its capacity to either
induce or limit inflammation under specific conditions
(Fig. 1). In some circumstances, TLR or death receptors
can activate pro-inflammatory interleukin (IL)-1β, either
caspase-8 activation of the Nod-like receptor 3 (NLRP3)–
caspase-1 inflammasome [6]. Moreover, caspase-8 also acts
in a pro-survival capacity, because its catalytic activity is
essential for suppressing TLR and death receptor-mediated
necroptotic killing [7]. When caspase-8 function is com-
promised, TLRs or TNFR1 signal through the receptor
interacting protein kinase RIPK1 to induce the
oligomerization and kinase activity of RIPK3. Subsequently,
RIPK3 phosphorylates mixed lineage kinase domain-like
(MLKL), and MLKL then inserts into cellular membranes,
including the plasma membrane, to disrupt their integrity.
Unlike apoptotic cell death, necroptosis-induced cellular
rupture is thought to trigger inflammation through the
release of intracellular danger molecules, termed damage-
associated molecular patterns (DAMPs). Consistent with
this, genetic inactivation of caspase-8 can signal necropto-
sis to cause inflammation, and necroptotic killing has beenicle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Inflammatory responses caused by caspase-8 activation, or deletion, in innate-immune cells. (Left) Other than inducing apoptosis, when
activated through TLR, dectin-1 or death receptor signalling, caspase-8 has been reported to activate IL-1β through either the NLRP3–caspase-1
inflammasome or by direct proteolytic IL-1β processing. RIPK3 and caspase-8 signalling downstream of TLR4 is also required for efficient cytokine
production independent of their ability to induce cell death. (Right) When caspase-8 is lost, TLR or TNFR1 ligation can activate RIPK1/RIPK3 to
induce cytokine production, drive RIPK3–MLKL-dependent necroptosis (and DAMP release) or activate the NLRP3 inflammasome to generate
bioactive IL-1β. IL interleukin, MLKL mixed lineage kinase domain-like, NLRP3 Nod-like receptor 3, RIPK receptor interacting protein kinase, TLR
Toll-like receptor, TNFR1 tumour necrosis factor receptor 1
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and renal ischaemic reperfusion injury [7].
Macrophage survival during differentiation was previ-
ously reported to require caspase-8 expression [8], con-
sistent with its role in keeping RIPK3-induced necroptosis
signalling in check. However, Cuda et al. [1] now report
relatively efficient caspase-8 deletion in neutrophils,
monocytes and macrophages (Casp8fl/fl LysMCre). These
mice developed mild systemic inflammation, presenting
with splenomegaly and lymphadenopathy, increased
splenic monocytes/macrophages, and a slight serological
elevation in a subset of cytokines and chemokines. Strik-
ingly, antibiotic treatment rescued the splenomegaly and
lymphadenopathy in Casp8fl/fl LysMCre mice, implying that
intestinal microflora trigger the abnormal immune re-
sponses following myeloid cell-specific caspase-8 loss.
Similarly, co-deletion of RIPK3 in Casp8fl/fl LysMCre mice
restored all inflammatory markers to normal. This implies
that caspase-8 deletion alone is insufficient to trigger
spontaneous RIPK3 signalling, but that upon microbe-
dependent TLR engagement, caspase-8 blunts aberrant
RIPK3 activity.
The tissue or cell-type specific deletion of caspase-8
has frequently been observed to induce a strong pro-
inflammatory phenotype that is rescued by RIPK3 co-
deletion [7]. Although DAMP release from dying cells is
presumed to be the major inflammatory trigger, acti-
vated RIPK1/3 may also promote transcriptional cyto-
kine responses [9,10]. Consistent with the latter, Cuda
et al. observed that resting, M1 polarized or TLR-
stimulated caspase-8-deficient macrophages displayed a
distinct transcriptional profile, which was restored upon
RIPK1 inhibition. These data imply that cell-intrinsicRIPK1/3-mediated gene induction contributes to the
phenotype of Casp8fl/fl LysMCre mice, independent of
necroptotic DAMP release.
Caspase-8 deletion in dendritic cells (DCs) sensitizes
mice to lipopolysaccharide (LPS)-induced lethality
resulting from excess RIPK3-driven NLRP3 inflamma-
some activation and IL-1β production [11]. Similarly,
caspase-8 deletion in the skin or gut triggers severe in-
flammation that is dependent on RIPK3 [12]. Somewhat
contrary to expectations, Cuda et al. demonstrate that
the injection of LPS into Casp8fl/fl LysMCre mice results in
reduced cytokine production compared with wild-type
controls. This infers that caspase-8 may be required for
optimal TLR-induced cytokine transcriptional responses,
as observed previously in LPS-treated caspase-8 and
RIPK3 doubly-deficient mice and macrophages [13]. The
reduced cytokine production also suggests that LPS-
triggered IL-1β activation could depend on caspase-8
activation of NLRP3–caspase-1, or on direct caspase-8
proteolysis of precursor IL-1β. Alternatively, it is also
possible that LPS-induced necroptosis of caspase-8-
deficient myeloid cells in vivo may blunt their capacity
for producing inflammatory cytokines.
In summary, the research by Cuda et al. expands our
knowledge of the multifaceted roles of caspase-8 in
regulating immune responses. Although results point
towards increased RIPK3 signalling causing aberrant
TLR responses following caspase-8 loss in myeloid cells,
it remains unclear how much of the in vivo phenotype is
driven by necroptosis versus RIPK3-induced inflamma-
tory cytokine production. In this regard, the co-deletion
of the requisite downstream necroptotic protein MLKL
in caspase-8-deficient myeloid cells may be particularly
Sagulenko et al. Arthritis Research & Therapy  (2016) 18:4 Page 3 of 3informative, because this would leave much of the
RIPK1/3 inflammatory signalling capacity intact. Not-
ably, the phenotype observed in myeloid cell-deficient
caspase-8 mice contrasts with results observed upon
caspase-8 deletion in DCs, which induces a more pro-
nounced autoimmune phenotype that is not fully RIPK3
dependent [11,14]. This serves to highlight immune cell-
type specific roles for caspase-8 that are critical for shap-
ing both innate and adaptive immune responses.
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